Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Ann Surg Oncol. 2021 Feb 22;28(9):5121–5131. doi: 10.1245/s10434-021-09710-8

Table III.

Performance and Calibration Measures

Development Cohort External Validation Cohort
Apparent Model Internal Validation Bootstrapped Model External Validated Recalibrated model
Overall Complication
C-Statistic 0.72 0.72 0.70 0.70
Slope 1.00 0.99 0.91 1.00
Intercept 0.00 −0.02 −0.33 0.00
Brier Score 0.05 0.05 0.04 0.04
HLT 0.21 0.21 0.02 0.24

Infectious Complication
C-Statistic 0.70 0.67 0.67 0.67
Slope 1.00 0.99 0.95 1.00
Intercept 0.00 −0.04 −0.19 0.00
Brier Score 0.04 0.04 0.03 0.03
HLT 0.25 0.25 0.51 0.60

Internal Organ Complication
C-Statistic 0.81 0.80 0.74 0.74
Slope 1.00 0.98 0.88 1.00
Intercept 0.00 −0.08 −0.67 0.00
Brier Score 0.006 0.006 0.004 0.003
HLT 0.14 0.14 0.84 0.97

Hematologic Complication
C-Statistic 0.84 0.84 0.84 0.84
Slope 1.00 0.98 0.96 1.00
Intercept 0.00 −0.06 −0.31 0.00
Brier Score 0.01 0.01 0.009 0.009
HLT 0.44 0.44 0.42 0.86

HLT: Hosmer Lemeshow test statistic; C-Statistic: concordance statistic or area under the curve